VAERS reports by lot

GSK Varicella/Shingles lot B4C42: VAERS reports

73 VAERS reports list lot B4C42 as a GSK Varicella/Shingles vaccine, received between 2018-02-19 and 2019-10-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
73
Reports
4%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction7931%
General / Systemic (non-local)6626%
Neurological2510%
Musculoskeletal229%
Dermatological (non-injection-site)218%
Gastrointestinal125%
Cardiac / Cardiovascular94%
Allergic / Anaphylactic83%
Psychiatric / Neuropsychiatric62%
Respiratory52%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

California11
Washington6
Colorado6
Arizona6
North Carolina5
Georgia5
Oregon4
Tennessee4
Texas4
Florida4
Idaho3
Missouri3

Reports by month received

2018-022
2018-035
2018-0420
2018-0520
2018-0611
2018-076
2018-082
2018-094
2018-101
2018-121
2019-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.